TB500 (Thymosin B4 Acetate)

What is TB-500?

TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (gene symbol TMSB4X), a 43-amino-acid protein found endogenously in nearly all human and mammalian cells. The TB-500 fragment corresponds to the active region of Thymosin Beta-4 that mediates its primary biochemical function: binding to monomeric G-actin. Molecular formula C₂₁₂H₃₅₀N₅₆O₇₈S, molecular weight approximately 4,963 g/mol.

Research Context

TB-500 is studied across the preclinical literature in cytoskeletal research, with particular focus on actin-binding kinetics and cellular migration assays. Standard research models include cultured endothelial cells, fibroblast cell lines, and in-vitro wound-closure assay systems. The compound’s high water solubility makes it well-suited to standard aqueous buffer systems used in cell-culture protocols, and its larger molecular size relative to BPC-157 places it in a different physicochemical category for purification and storage methodology.

Mechanism of Action (Research Framing)

The published primary mechanism of TB-500 centers on its high-affinity binding to monomeric G-actin via a specific actin-binding motif preserved within the fragment sequence. By sequestering G-actin from the cellular monomer pool, the peptide modulates the dynamic equilibrium between G-actin (monomer) and F-actin (polymer) — the central machinery of cell motility, cytoskeletal remodeling, and intracellular cargo transport.

Specific molecular interactions documented in the published literature include:

• Actin sequestration — the canonical primary mechanism; the fragment binds one G-actin monomer per peptide molecule with submicromolar affinity in published binding studies
• Integrin signaling — secondary literature investigates TB-500’s modulation of cell-surface integrin engagement and downstream focal adhesion kinase pathway research
• VEGF expression — published work in cultured endothelial models examines TB-500 effects on vascular endothelial growth factor transcription
• MAPK cascade activation — downstream signaling research in cultured cell preparations

The peptide is also used as a research probe for actin-dependent cellular processes in mechanistic studies where actin dynamics are the experimental endpoint.

Standard Research Assays

Published TB-500 research commonly employs the following methodologies:

• F-actin polymerization assays measuring fluorescence kinetics of labeled actin
• Scratch-wound migration assays in cultured endothelial or fibroblast monolayers
• Transwell migration and invasion assays
• Immunofluorescence staining for actin cytoskeleton organization (phalloidin labeling)
• Live-cell imaging of migration kinetics in time-lapse microscopy
• qPCR and Western blot analysis of integrin and VEGF expression in treated cultures
• Capillary tube formation assays in Matrigel for angiogenesis research
• Co-immunoprecipitation studies of actin-binding partner proteins
• Surface plasmon resonance for direct measurement of G-actin binding kinetics
• Confocal microscopy of cytoskeletal reorganization in live cells
• Atomic force microscopy of cytoskeletal mechanical properties
• Mass spectrometry-based proteomics for actin-interactome characterization following exposure
• High-content imaging screens with automated quantification of cellular migration phenotype across multi-well plate formats

The compound’s actin-binding affinity is well-characterized; researchers replicating published binding kinetics should verify their stock solution concentration via absorbance at 215 nm or quantitative HPLC before assay setup.

Why Purity Matters for Research Validity

For a 43-residue-class peptide fragment like TB-500, common synthesis byproducts include truncated sequences (chains missing one or more amino acids at the N- or C-terminus), deletion mutants, and oxidation variants — particularly at methionine residues. A 95% pure TB-500 sample may contain enough truncated fragment to skew actin-binding kinetics measurements by 10–15%, which is precisely the effect size most published binding assays are designed to detect. The difference between research-grade and laboratory-grade purity is therefore not academic; it determines whether your data is signal or artifact.